EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exploring Corresponding Cutpoints for Hypoglycaemia Awareness Questionnaire ( HypoA ‐Q) Impaired Awareness Subscale in Relation to the Gold and Clarke Measures: A Post Hoc Analysis From the Hypo‐ METRICS Study

Vaios Koutroukas iD, Aikaterina Tziannou, Uffe Søholm, Jonah J C Thomas iD, Gilberte Martine-Edith, Simon Heller iD, Julia K Mader iD, Ulrik Pedersen-Bjergaard iD, Bastiaan E de Galan, Eric Renard iD, Mark L Evans iD, Rory McCrimmon iD und 6 weitere

Diabetes, Obesity and Metabolism · 03.11.2026

DOI: 10.1111/dom.71504 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 03.11.2026. Verfasst von Vaios Koutroukas und 17 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Research Centre, University of Leicester, College of Life Sciences, Leicester, UK. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovative Medicines Initiative 2 Joint Undertaking (JU).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The Hypoglycaemia Awareness Questionnaire–Impaired Awareness subscale (HypoA‐Q/IA) was developed to enhance impaired awareness of hypoglycaemia (IAH) assessment, addressing methodological deficiencies of the established Gold and Clarke measures. An IAH cutpoint (HypoA‐Q/IA ≥ 12) was identified from a clamp study in Type 1 diabetes (T1D). We explored cutpoints in relation to Gold and Clarke measures, and their co‐occurrence, in the larger, real‐world observational Hypo‐METRICS study, in people with T1D (pwT1D) and insulin‐treated Type 2 diabetes (pwT2D). Material and Methods Hypo‐METRICS recruited pwT1D or pwT2D with ≥ 1 hypoglycaemic event in the previous 3 months. IAH was defined as Gold ≥ 4, Clarke ≥ 4 and/or HypoA‐Q/IA ≥ 12. Bidirectional ROC analysis was performed between HypoA‐Q/IA and Gold/Clarke cutpoints.

Results

Questionnaires were completed by 232 pwT1D and 285 pwT2D (male 47% vs. 62%, p < 0.001; median age 49 vs. 63 years, p < 0.001; HbA1c 7.3% vs. 7.4%, p = 0.03). IAH prevalence was 24% by Gold ≥ 4, 16% by Clarke ≥ 4 and 7% by HypoA‐Q/IA ≥ 12. ROC analysis yielded HypoA‐Q/IA cutpoints of ≥ 7 against Gold ≥ 4 (AUC 0.87) and ≥ 9 against Clarke ≥ 4 (AUC 0.89), and cutpoints of Gold ≥ 4 (AUC 0.87) and Clarke ≥ 3 (AUC 0.93) against HypoA‐Q/IA ≥ 12. Of those with IAH by either measure, 24% were identified by both HypoA‐Q/IA ≥ 12 and Gold ≥ 4, and 32% by both HypoA‐Q/IA ≥ 12 and Clarke ≥ 4, with lower overlap in T2D than T1D.

Conclusions

HypoA‐Q/IA cutpoints corresponding to legacy IAH cutpoints (≥ 7–9) were lower than the clamp‐derived threshold (≥ 12), suggesting ≥ 12 may identify a subgroup with more severe IAH. These cutpoints enable cross‐study comparison; prospective validation against severe hypoglycaemia risk is needed.

Schlagwörter

Stichwörter der Autor:innen

Type 1 diabetesType 2 diabetescontinuous glucose monitoring (CGM)hypoglycaemia

Autor:innen und Institutionen

  • Diabetes Research Centre, University of Leicester, College of Life Sciences, Leicester, UK.
  • Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK.
  • School of Psychology, Institute for Health Transformation, Deakin University, Geelong, Victoria, Australia.
  • The Australian Centre for Behavioural Research in Diabetes, Diabetes Victoria, Carlton, Victoria, Australia.
  • Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield, Sheffield, UK.
  • Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.

ORCID-Profile: Vaios Koutroukas, Jonah J C Thomas, Simon Heller, Julia K Mader, Ulrik Pedersen-Bjergaard, Eric Renard, Mark L Evans, Rory McCrimmon

Förderung

  • Innovative Medicines Initiative 2 Joint Undertaking (JU)

Zitieren

APA

Koutroukas, V., Tziannou, A., Søholm, U., Thomas, J. J. C., Martine-Edith, G., Heller, S., Mader, J. K., Pedersen-Bjergaard, U., de Galan, B. E., Renard, E., Evans, M. L., McCrimmon, R., Pouwer, F., Amiel, S. A., Shaw, J. A. M., Speight, J., Choudhary, P., & Hypo‐RESOLVE Consortium (2026). Exploring Corresponding Cutpoints for Hypoglycaemia Awareness Questionnaire ( HypoA ‐Q) Impaired Awareness Subscale in Relation to the Gold and Clarke Measures: A Post Hoc Analysis From the Hypo‐ METRICS Study. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.71504

Vancouver

Koutroukas V, Tziannou A, Søholm U, Thomas JJC, Martine-Edith G, Heller S, et al. Exploring Corresponding Cutpoints for Hypoglycaemia Awareness Questionnaire ( HypoA ‐Q) Impaired Awareness Subscale in Relation to the Gold and Clarke Measures: A Post Hoc Analysis From the Hypo‐ METRICS Study. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.71504

BibTeX
@article{Koutroukas2026,
  author = {Koutroukas, Vaios and Tziannou, Aikaterina and Søholm, Uffe and Thomas, Jonah J C and Martine-Edith, Gilberte and Heller, Simon and Mader, Julia K and Pedersen-Bjergaard, Ulrik and de Galan, Bastiaan E and Renard, Eric and Evans, Mark L and McCrimmon, Rory and Pouwer, Frans and Amiel, Stephanie A and Shaw, James A M and Speight, Jane and Choudhary, Pratik and Hypo‐RESOLVE Consortium, Hypo‐RESOLVE Consortium},
  title = {Exploring Corresponding Cutpoints for Hypoglycaemia Awareness Questionnaire ( HypoA ‐Q) Impaired Awareness Subscale in Relation to the Gold and Clarke Measures: A Post Hoc Analysis From the Hypo‐ METRICS Study},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  doi = {10.1111/dom.71504}
}
Kostenlos starten →